Clinical annotation of ABAT in the METABRIC cohort

A. Survival differences between ABAT low and high expression groups. B. CoxPH model identifying the prediction ability of ABAT. C. Most correlated genes of ABAT based on Spearman’s correlation analysis. D. Relative expression of ABAT in the ER-negative and ER-positive groups. E. Correlation between the relative expression of ABAT and the IFN-γ score. F. Correlation between the relative expression of ABAT and the stemness score. ABAT, 4-aminobutyrate aminotransferase; METABRIC, the Molecular Taxonomy of Breast Cancer International Consortium; CI, confidence interval; HR, hazard ratio.